Optogenetics enlightens neuroscience drug discovery

被引:0
|
作者
Chenchen Song
Thomas Knöpfel
机构
[1] Imperial College London,Division of Brain Sciences, Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Optogenetics uses light and genetics to manipulate and monitor the activities of defined cell populations, and this technique has transformed basic neuroscience research.Optogenetic tools are genetically encoded proteins designed to manipulate and monitor neuronal circuits, and there are two types of proteins used: actuators (proteins that transduce light into neuronal signals for manipulation) and indicators (proteins that transduce neuronal signals into optical signals for monitoring).An optogenetic approach involves light-based (optical) interventions and/or recordings of natural neural activity to elucidate the role of specified neuronal circuit elements in mammalian behaviour.Numerous cognitive and emotional functions have already been studied using optogenetic approaches, including sensory perception, pain, decision-making, preference and avoidance, social interactions, and feeding behaviour; optogenetics has also been used in animal models of neuropsychiatric conditions.Animal models for optogenetically induced disease states may facilitate the evaluation of drug candidates.Optogenetics paves the way to novel therapeutic approaches in which chemistry is replaced by micro-optoelectronics and genetic modification of specific cells and in which modulation of specific neuronal circuits is the central mechanism of action.
引用
收藏
页码:97 / 109
页数:12
相关论文
共 50 条
  • [21] Employing optogenetics for auditory neuroscience and cochlear implants
    Keppeler, D.
    Hernandez, V. H.
    Gehrt, A.
    Jeschke, M.
    Wrobel, C.
    Hoch, G.
    Gossler, C.
    Schwaerzle, M.
    Strenzke, N.
    Salditt, T.
    Kuegler, S.
    Ruther, P.
    Schwarz, U. T.
    Moser, T.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S245 - S245
  • [22] Integration of optogenetics with complementary methodologies in systems neuroscience
    Christina K. Kim
    Avishek Adhikari
    Karl Deisseroth
    Nature Reviews Neuroscience, 2017, 18 : 222 - 235
  • [23] Optogenetics: 10 years of microbial opsins in neuroscience
    Karl Deisseroth
    Nature Neuroscience, 2015, 18 : 1213 - 1225
  • [24] Let's get some structure into neuroscience drug discovery
    England, Steve
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (07) : 622 - 623
  • [25] Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
    McArthur, Robert A.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 76 : 4 - 21
  • [26] Using Stem Cell Derived Neurons for Drug Discovery in Neuroscience
    Dolmetsch, Ricardo
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S11 - S11
  • [27] Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
    Salomone, Salvatore
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [28] Highlight: Horizons in Neuroscience - Organoids, Optogenetics and Remote Control
    Heumann, Rolf
    BIOLOGICAL CHEMISTRY, 2024, 405 (01) : 1 - 3
  • [29] DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug Discovery
    Li, Jingyao
    Ho, Daniel J.
    Henault, Martin
    Yang, Chian
    Neri, Marilisa
    Ge, Robin
    Renner, Steffen
    Mansur, Leandra
    Lindeman, Alicia
    Kelly, Brian
    Tumkaya, Tayfun
    Ke, Xiaoling
    Soler-Llavina, Gilberto
    Shanker, Gopi
    Russ, Carsten
    Hild, Marc
    Keller, Caroline Gubser
    Jenkins, Jeremy L.
    Worringer, Kathleen A.
    Sigoillot, Frederic D.
    Ihry, Robert J.
    ACS CHEMICAL BIOLOGY, 2022, 17 (06) : 1401 - 1414
  • [30] Editorial overview: Neurosciences: Clinical pharmacology today in neuroscience drug discovery
    Trist, David G.
    Bye, Alan
    CURRENT OPINION IN PHARMACOLOGY, 2014, 14 : V - VI